Geode Capital Management, LLC Idera Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.23 - $0.43 $214 - $400	-932 Reduced 0.23%	396,871 $138,000
Q2 2022 Aug 12, 2022	BUY	$0.32 - $0.74 $7,782 - $17,996	24,320 Added 6.51%	397,803 $182,000
Q3 2021 Nov 12, 2021	BUY	$1.0 - $1.18 $52,633 - $62,106	52,633 Added 16.4%	373,483 $384,000
Q2 2021 Aug 13, 2021	BUY	$1.01 - $1.58 $63,022 - $98,590	62,399 Added 24.14%	320,850 $385,000
Q1 2021 May 12, 2021	BUY	$1.23 - $5.98 $69,765 - $339,185	56,720 Added 28.12%	258,451 $335,000
Q4 2020 Feb 12, 2021	BUY	$2.09 - $5.18 $47,593 - $117,958	22,772 Added 12.72%	201,731 $740,000
Q3 2019 Nov 12, 2019	SELL	$2.12 - $3.31 $2,329 - $3,637	-1,099 Reduced 0.61%	178,959 $517,000
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $176,790 - $296,142	-74,595 Reduced 29.29%	180,058 $480,000
Q1 2019 May 14, 2019	BUY	$2.33 - $3.79 $56,097 - $91,248	24,076 Added 10.44%	254,653 $649,000
Q4 2018 Feb 13, 2019	BUY	$2.77 - $9.38 $23,456 - $79,429	8,468 Added 3.81%	230,577 $638,000
Q3 2018 Nov 13, 2018	SELL	$5.53 - $11.36 $8.23 Million - $16.9 Million	-1,489,085 Reduced 87.02%	222,109 $1.98 Million
Q2 2018 Aug 14, 2018	BUY	$9.92 - $16.96 $17 Million - $29 Million	1,711,194 New	1,711,194 $2.26 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.